α-Acetyldigoxin
Jump to navigation
Jump to search
This article needs additional citations for verification. (August 2007) |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 90%(Oral) |
Protein binding | 20–30% |
Elimination half-life | 40h |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C43H66O15 |
Molar mass | 822.986 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
α-Acetyldigoxin is a cardiac glycoside. It is an acetyl derivative of digoxin and an isomer of β-acetyldigoxin. It increases the contractility of the heart by its positive inotropic effect on cardiac muscle. The effects of α-acetyldigoxin begin 3–4 hours after administration, and maximize after 6–8 hours. It is prescribed for congestive chronic cardiac failure class II, III and IV.
External links
- α-acetyldigoxin in the ChemIDplus database
Categories:
- Articles needing additional references from August 2007
- All articles needing additional references
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- All stub articles
- Cardiovascular system drug stubs
- Cardenolides
- Acetate esters